Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Chaeum + Lidocaine
- Development stage
- Unknown
- Lead developer
- Hugel
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Administration
- Subcutaneous, Intradermal
01
Overview
The Chaeum + Lidocaine (also known as The Chaeum Premium) is a monophasic, cross-linked hyaluronic acid (HA) dermal filler developed by Hugel. It contains HA at a concentration of 20-24 mg/ml and 0.3% lidocaine hydrochloride to minimize patient discomfort during injection. The product utilizes a proprietary low-temperature cross-linking technology to minimize BDDE (1,4-butanediol diglycidyl ether) residues, ensuring a high safety profile. It is indicated for the temporary improvement of facial wrinkles and for central facial volume augmentation. The product line includes various formulations (Premium 1, 2, 3, and 4) with different viscosities and cross-linking rates to target specific treatment depths, from fine lines to deep folds and facial contouring.
- Brand names
- The Chaeum PureThe Chaeum Shape
- Other names
- The Chaeum (+Lidocaine)The Chaeum Plus LidocaineHugel Hyaluronic Acid Filler
02
Targets
SCN10A (Sodium channel protein type X alpha subunit)
Beyond the preview
Go deeper on The Chaeum + Lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Chaeum + Lidocaine.